Related Experiment Video
Updated: Apr 30, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Hyperhomocysteinemia, lipid and lipoprotein disturbances in patients with primary hypertension
Aleksandra Baszczuk1, Katarzyna Musialik2, Jarosław Kopczyński2
1Department of Laboratory Diagnostics, Poznan University of Medical Sciences, Poznan, Poland.
Insights
Patients with primary hypertension and hyperhomocysteinemia exhibit lower HDL-cholesterol and apo A-I levels. Elevated homocysteine correlates negatively with these lipid and lipoprotein parameters, suggesting increased atherosclerosis risk.
Area of Science:
- Cardiovascular Medicine
- Clinical Biochemistry
- Lipid Metabolism
Background:
- Primary hypertension is a significant risk factor for cardiovascular disease.
- Hyperhomocysteinemia, elevated homocysteine levels, is also linked to increased cardiovascular risk.
- The interplay between hypertension, hyperhomocysteinemia, and lipid profiles requires further elucidation.
Purpose of the Study:
- To determine serum concentrations of lipids and lipoproteins in patients with primary hypertension and hyperhomocysteinemia.
- To investigate correlations between homocysteine levels and lipid/lipoprotein parameters in hypertensive patients.
Main Methods:
- Study included 42 patients with primary hypertension and hyperhomocysteinemia, and 20 healthy controls.
- Homocysteine measured by Fluorescence Polarization Immunoassay (FPIA).
- Lipids (total cholesterol, LDL-C, HDL-C, triglycerides) measured enzymatically.
- Apolipoproteins (apo A-I, apo B) and lipoprotein(a) measured nephelometrically.
Main Results:
- Patients with primary hypertension and hyperhomocysteinemia showed significantly lower HDL-cholesterol and apo A-I concentrations compared to hypertensive individuals with normal homocysteine.
- A negative correlation was observed between homocysteine levels and HDL-cholesterol.
- A negative correlation was also found between homocysteine and apo A-I.
Conclusions:
- The findings suggest that individuals with primary hypertension and hyperhomocysteinemia may have a higher susceptibility to atherosclerosis.
- Lower HDL-cholesterol and apo A-I in this population underscore the combined atherogenic risk.
- Further research is warranted to explore therapeutic strategies targeting homocysteine and lipid profiles in hypertensive patients.
Purposes:
The main aim of the study was to answer two questions: what are the concentrations of total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, apo A-I (apolipoprotein A-I), apo B (apolipoprotein B) and Lp(a) (lipoprotein(a)) in serum of patients with primary hypertension and with hyperhomocysteinemia? Is there any correlation between the concentration of homocysteine in blood serum and investigated lipid and lipoprotein parameters in patients with primary hypertension?
Material/Methods:
We investigated 42 patients with primary hypertension, aged 22-57. The control group consisted of 20 healthy volunteers. The concentration of homocysteine in serum was evaluated using immunochemical method (FPIA - Fluorescence Polarization Immunoassay). The concentration of total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides in blood serum were estimated using enzymatic method. Apo A-I, apo B and lipoprotein(a) were assessed using nephelometric method.
Results:
The analysis of the results revealed statistically significant lower concentrations of HDL-cholesterol and apo A-I in blood serum of patients with primary hypertension and hyperhomocysteinemia than in the population with hypertension and normohomocysteinemia. Negative correlation between homocysteine and HDL-cholesterol as well as apo A-I has been revealed.
Conclusion:
Quantitative analysis of the concentration of lipids and lipoproteins in blood serum in patients with primary hypertension and hyperhomocysteinemia may suggest that this type of human population might be more susceptible to atherosclerosis than those with primary hypertension and normal values of homocysteine.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension and Regulation of Blood Pressure
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Hypertension II: Pathophysiology